ENGVALL et al. V. DAVID et al. - Page 44




                USPQ2d 1610, 1614 (Fed. Cir. 1997), quoting Breen v. Henshaw, 472 F.2d 1398, 1401, 176 USPQ                                
                519, 521 (CCPA 1973).                                                                                                      
                                2.      Engvall’s alleged conception                                                                       
                        We conclude, that based on the record before us, Engvall has failed to prove a conception of                       
                                                  61                                                                                       
                the subject matter of the count.                                                                                           
                                        a.       Engvall’s  alleged  conception  of  the  use  of  monoclonal                              
                                                 antibodies having affinity constants of at least about 108                                
                                                 liters/mole                                                                               
                        After careful review of the record and consideration of Engvall’s arguments, we conclude that                      
                Engvall has not proved conception of every limitation of the count prior to August 4, 1980, the filing                     
                date of David’s application. In particular, Engvall has not shown that she had possession of the                           
                conception of an immunometric assay where both monoclonal antibodies had affinity constants of “at                         
                least about 10  liters/mole” as specifically required by the count.8                                                                                                           
                        Engvall  argues  that  the  evidence  shows  the  conception  of  the  use  of “high  affinity”                    
                monoclonal antibodies.   However, the weight of the evidence does not establish what the Engvall                           
                inventors considered to be a “high affinity.”  Implicit in Engvall’s argument is that the generic phrase                   
                “high affinity” includes antibodies within the scope of the count.  However, the fact that antibodies                      
                within the scope of the count arguably might be within the scope of the generic phrase “high affinity,”                    
                that phrase does not constitute a definite description of monoclonal antibodies having an affinity                         
                constant of “at least about 10  liters/mole” as required by the count. See Bosies, 27 F.3d at 542, 308                                                                                           
                USPQ2d at 1865 (“Although the compounds of the count arguably might be within the scope of the                             
                generic formula set out in Benedict’s notebook, that formula does not constitute a definite description                    
                of the compounds of the count.”).                                                                                          

                        61                                                                                                                 
                                In the preliminary statement, Engvall asserts of a date of conception of mid-December 1978.  We            
                could interpret “mid-December” to mean December 16, 1978.  This would be the earliest date upon which Engvall may          
                rely in this proceeding.  37 CFR § 1.629(a) and (b).  In her briefs, Engvall asserts a conception date of Fall of 1978. Fall,
                of course, runs from September 21 to December 21. However, Engvall is estopped from asserting any date earlier than        
                set out in the preliminary statement.  37 CFR § 1.629(a) and (b);  Dewey v. Lawton, 347 F.2d 629, 630-31, 146 USPQ         
                187, 188 (CCPA 1965). And where a time period is asserted, the date is presumed to be the last day of the period.  Oka,    
                849 F.2d at 584, 7 USPQ2d at 1172.   We could, therefore, use December 21 as the alleged date of conception.               
                Additionally, Engvall apparently considers “Fall, 1978" to include dates prior to January 3, 1979.  Engvall Brief, pp. 70- 
                71.   Thus, we could interpret Engvall’s assertion of Fall, 1978, as an allegation of a date no earlier than January 3,    
                1979.  However, regardless of which date is used, we hold that Engvall has failed to prove a conception of the subject     
                matter of the count.                                                                                                       
                                                                    41                                                                     





Page:  Previous  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  Next 

Last modified: November 3, 2007